Literature DB >> 22740872

Ewing's sarcoma: A case report of a 52-year-old woman with recurrent tumor and literature review.

Waseem Khaliq1, Mohammad Farshad Bahador, Thomas Nichols Laurence, Ronald Andrew Sapiente, James Sheridan Lewis, David Lee Graham.   

Abstract

Ewing's sarcoma is the second most common primary sacral tumor. Ewing's sarcomas are rare, aggressive tumors with a tendency towards recurrence following resection and early metastasis. Although peak incidences are between the ages of 10 and 20 years, patients of younger or older age account for almost 30% of the cases. We report the case of a 52-year-old healthy female who presented with a 2-week history of pain in her right posterior thigh that was unable to be relieved by non-steroidal anti-inflammatory medicine and physical therapy. Magnetic resonance imaging demonstrated an irregular right presacral mass and core needle biopsy revealed a small, round blue cell neoplasm. Staging workup was normal and an open biopsy was positive for the ES translocation (22q12). The patient was treated with 17 cycles of vincristine, adriamycin and cytoxan with mesna rescue, alternating with ifosfamide and etoposide in addition to external beam radiation. Post-treatment imaging demonstrated complete resolution of the tumor. Six weeks post-treatment the patient presented with a recurrent tumor. This case emphasizes the importance of timely establishment of initial diagnosis, early metastasis in treatment responsive patients and under-utilization of positron emission tomography-computed tomography (PET-CT) during the treatment to detect sub-clinical metastasis.

Entities:  

Year:  2011        PMID: 22740872      PMCID: PMC3362343          DOI: 10.3892/ol.2011.440

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  15 in total

Review 1.  Very late local recurrence of Ewing's sarcoma--can you ever say 'cured'? A report of two cases and literature review.

Authors:  S A Hanna; L A David; P D Gikas; A J Tindall; S R Cannon; T W R Briggs
Journal:  Ann R Coll Surg Engl       Date:  2008-10       Impact factor: 1.891

2.  Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years.

Authors:  Gaetano Bacci; Alba Balladelli; Cristiana Forni; Stefano Ferrari; Alessandra Longhi; Patrizia Bacchini; Marco Alberghini; Nicola Fabbri; Mariaserena Benassi; Antonio Briccoli; Piero Picci
Journal:  Cancer       Date:  2007-02-15       Impact factor: 6.860

3.  Thromboembolism in children with sarcoma.

Authors:  Uma Athale; Stephanie Cox; Sabrina Siciliano; Anthony K C Chan
Journal:  Pediatr Blood Cancer       Date:  2007-08       Impact factor: 3.167

4.  Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.

Authors:  Torunn I Yock; Mark Krailo; Christopher J Fryer; Sarah S Donaldson; James S Miser; Zhengjia Chen; Mark Bernstein; Fran Laurie; Mark C Gebhardt; Holcombe E Grier; Nancy J Tarbell
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

Review 5.  The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors.

Authors:  H E Grier
Journal:  Pediatr Clin North Am       Date:  1997-08       Impact factor: 3.278

6.  Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

Authors:  Holcombe E Grier; Mark D Krailo; Nancy J Tarbell; Michael P Link; Christopher J H Fryer; Douglas J Pritchard; Mark C Gebhardt; Paul S Dickman; Elizabeth J Perlman; Paul A Meyers; Sarah S Donaldson; Sheila Moore; Aaron R Rausen; Teresa J Vietti; James S Miser
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

Review 7.  The molecular pathology of small round-cell tumours--relevance to diagnosis, prognosis, and classification.

Authors:  A P McManus; B A Gusterson; C R Pinkerton; J M Shipley
Journal:  J Pathol       Date:  1996-02       Impact factor: 7.996

8.  Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group.

Authors:  Patrick J Leavey; Leo Mascarenhas; Neyssa Marina; Zhengjia Chen; Mark Krailo; James Miser; Ken Brown; Nancy Tarbell; Mark L Bernstein; Linda Granowetter; Mark Gebhardt; Holcombe E Grier
Journal:  Pediatr Blood Cancer       Date:  2008-09       Impact factor: 3.167

Review 9.  Sarcoma.

Authors:  Keith M Skubitz; David R D'Adamo
Journal:  Mayo Clin Proc       Date:  2007-11       Impact factor: 7.616

10.  Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997.

Authors:  G Bacci; S Ferrari; A Longhi; D Donati; M De Paolis; C Forni; M Versari; E Setola; A Briccoli; E Barbieri
Journal:  Ann Oncol       Date:  2003-11       Impact factor: 32.976

View more
  2 in total

1.  Ewing's sarcoma in maxilla.

Authors:  Madhusudan Astekar; Shipra Saxena; Aditi Murari; Bhari Sharanesha Manjunatha
Journal:  BMJ Case Rep       Date:  2019-02-21

2.  Early recognition and diagnosis of Ewing sarcoma of the cervical spine.

Authors:  Shazia Rahat Chaudhry; Caleb Tsetse; Sajeev Ezhapilli Chennan
Journal:  Radiol Case Rep       Date:  2018-11-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.